January 3, 2020 News by Alejandra Viviescas, PhD DMT Use Linked to Fewer Hospitalizations Among Adults with MS in Canadian Province The growing reliance on disease-modifying therapies (DMTs)Â to treat people with multiple sclerosis (MS)Â has led to fewer hospitalizations but not a drop in the number of physician visits, a population study of DMTs and their impact on healthcare use in Canada reports. The study, “Association between…
December 5, 2019 News by Alejandra Viviescas, PhD 3D Nerve Cell Models of PPMS, Parkinson’s Ready for Liftoff to Space Station for Long-term Study in Microgravity The New York Stem Cell Foundation (NYSCF) Research Institute and Aspen Neuroscience will send three-dimensional brain cell models of primary progressive multiple sclerosis (PPMS) and Parkinson’s disease to the International Space Station (ISS) for the…
November 11, 2019 News by Alejandra Viviescas, PhD Low Neurite Density in Spinal Cord Linked to Greater Physical Disability in RRMS Patients People with relapsing-remitting multiple sclerosis (RRMS) have poorer neurite density — a measure that relates to the amount of nerve cell projections, including axons and dendrites involved in nerve-to-nerve communication — in the brain and spinal cord than do those without this disease, a study shows. This measure, especially…
October 24, 2019 News by Alejandra Viviescas, PhD SARM1 Inhibitors Protect Neurons from Damage in Mice and Cell Cultures, Results Presented at Neuroscience 2019 Show SARM1 inhibitors are a potential oral treatment to slow disease progression in neurodegenerative diseases like multiple sclerosis (MS), according to preclinical results that show the inhibitors protect nerve cells from damage in mice and cell cultures. Researchers at Disarm Therapeutics presented the findings in a poster titled “…
October 23, 2019 News by Alejandra Viviescas, PhD NfL and CHI3L1 Work as Biomarkers of Disease Activity and Progression in MS, Study Says The levels of neurofilament light chain (NfL) and chitinase3-like1 (CHI3L1) in the cerebrospinal fluid — the liquid that surrounds the brain and spinal cord — serve as respective biomarkers of disease activity and progression in multiple sclerosis (MS), a study reports. Measuring levels of both proteins also helps to…
August 22, 2019 News by Alejandra Viviescas, PhD Gene on X Chromosome May Be Reason Women at Higher Risk of MS, Study Says Females of certain species — like humans and mice — have a known ability to produce more of the gene Kdm6a than males because it’s located on the X chromosome, of which females have two. Kdm6a is also quite active in immune system T-cells, a study found, and silencing it in a mice model…
July 24, 2019 News by Alejandra Viviescas, PhD Conversion to MS Among Taiwanese with CIS Low and Disease Course Mild, Study Finds The percentage of Taiwanese who develop multiple sclerosis (MS) after an episode of clinically isolated syndrome (CIS) is lower than that reported for other ethnicities, and those who do progress are likely to have a milder disease course, a study found, supporting how factors like geography and genetics…
May 30, 2019 News by Alejandra Viviescas, PhD Canadians Wrap Up MS Awareness Month with ‘Acts of Greatness’ Campaign The Multiple Sclerosis (MS) Society of Canada closed its celebration of multiple sclerosis (MS) Awareness Month by launching the Acts of Greatness campaign that aims to raise $75 million to support research about the disease. The campaign was activated May 24 with the placements of five-meter decals…